Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sunniva Inc SNNVF

Industrials Biotechnology Conglomerates Cannabis
Sunniva Inc. is a Canada-based company. The Company is not engaged in any business.


GREY:SNNVF - Post by User

Sunniva Inc > The Bull case- 2019
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Bluechip2on Mar 08, 2019 7:46am
137 Views
Post# 29459815

RE:RE:The Bull case- 2019

RE:RE:The Bull case- 2019 @sunrize- yes that is true, federal legalization will definitely heavily favor cGMP compliant businesses. First of all, to meet the strict California guidelines regarding pesticide and heavy metal free cannabis, to do it at scale means to have a cGMP facility or similar quality product. Having that designation reduces the sampling and costs associated with testing for contaminants. As well, dispensaries weary of reputation, would obvious cater to companies with this designation. Also, as mentioned medical/pharmaceutical products would require this designation and California has the largest medical cannabis market (over 1 million) in North America. And lastly, having cGMP rated cannabis is a prerequisite for developing medical cannabis products in preparation for national/international launch post legalization.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities